Remy Luthringer
Tracked across 1 events · 6 articles · First seen Apr 02, 2026 · Last active Jun 01, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Remy Luthringer, CEO of Minerva Neurosciences, announced the formation of the Scientific Advisory Board and emphasized its importance for the development of Roluperidone and the company's pipeline.
Jun 01, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Remy Luthringer live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard